DL-3-n-butylphthalide for acute ischemic stroke: An updated systematic review and meta-analysis of randomized controlled trials
Background: DL -3-n-butylphthalide (NBP) is widely used as a neuroprotective drug in stroke patients in China. A systematic review in 2010 suggested NBP to be safe and effective at promoting neurological recovery, but could not conclude whether it decreased risk of long-term death or disability. Sin...
Main Authors: | Huan Wang, Kaili Ye, Dan Li, Yuxin Liu, Deren Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.963118/full |
Similar Items
-
Human urinary kallidinogenase or edaravone combined with butylphthalide in the treatment of acute ischemic stroke
by: Yun Qian, et al.
Published: (2019-12-01) -
Effect of Dl-3-n-Butylphthalide on olfaction in rotenone-induced Parkinson’s rats
by: Jiawei Wang, et al.
Published: (2024-04-01) -
Efficacy and Safety of Adherence to dl-3-n-Butylphthalide Treatment in Patients With Non-disabling Minor Stroke and TIA—Analysis From a Nationwide, Multicenter Registry
by: Zefeng Tan, et al.
Published: (2021-09-01) -
Corrigendum: Efficacy and Safety of Adherence to dl-3-n-Butylphthalide Treatment in Patients With Non-disabling Minor Stroke and TIA—Analysis From a Nationwide, Multicenter Registry
by: Zefeng Tan, et al.
Published: (2021-11-01) -
Rapid and improved oral absorption of N-butylphthalide by sodium cholate-appended liposomes for efficient ischemic stroke therapy
by: Ailing Zhang, et al.
Published: (2021-01-01)